Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Passage Bio Inc shares valued at $1,589 were sold by Forman Mark S on Feb 13 ’24. At $0.97 per share, Forman Mark S sold 1,638 shares. The insider’s holdings dropped to 48,631 shares worth approximately $41822.659999999996 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Borthwick Kathleen sold 1,470 shares, netting a total of over 1,426 in proceeds. Following the sale of shares at $0.97 each, the insider now holds 28,466 shares.
Before that, Forman Mark S had sold 15,813 shares from its account. In a trade valued at $14,390, the Chief Medical Officer traded Passage Bio Inc shares for $0.91 each. Upon closing the transaction, the insider’s holdings decreased to 15,813 shares, worth approximately $38931.34.
As published in a research note from JP Morgan on March 08, 2022, Passage Bio Inc [PASG] has been rated down from an Overweight to a Neutral. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid January. As of July 01, 2021, Raymond James has initiated its “an Outperform” rating for PASG. Earlier on June 15, 2021, BTIG Research initiated its rating. Their recommendation was “a Buy” for PASG stock.
Analyzing PASG Stock Performance
During the last five days, there has been a drop of approximately -5.94%. Over the course of the year, Passage Bio Inc shares have dropped approximately -15.07%. Shares of the company reached a 52-week high of $1.7900 on 03/06/24 and a 52-week low of $0.7900 on 07/01/24. A 50-day SMA is recorded $1.1835, while a 200-day SMA reached $1.0176. Nevertheless, trading volume fell to 68100.0 shares from 0.32 million shares the previous day.
Support And Resistance Levels for Passage Bio Inc (PASG)
According to the 24-hour chart, there is a support level at 0.8219, which, if violated, would cause prices to drop to 0.7520. In the upper region, resistance lies at 0.9908. The next price resistance is at 1.0898. RSI (Relative Strength Index) is 37.51 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0141, which suggests the price will decrease in the coming days. Percent R is at 66.10%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
